News and Announcements
OncoSil strengthens management team
- Published October 08, 2015 11:14AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
8th October 2015, ASX Announcement
OncoSil Medical Limited (ASX:OSL) (OncoSil Medical, the Company) is pleased to announces details of two new key appointments to its senior management team in preparation for the commercialisation of the Company’s OncoSilTM localised radiation treatment for cancer.
Mr David James appointed Global Head of Manufacturing Operations
Mr David James has been appointed the Company’s Global Head of Manufacturing Operations on a full-time basis effective from 5 October 2015, after initially working in the role in a part-time consultancy capacity since February.
Mr James is a highly experienced pharmaceutical manufacturing operations executive with more that 20 years’ experience in this field, including six years with leading cancer treatment company Sirtex Medical (ASX:SRX) as Global Operations Manager.
Dr Greg Rogers appointed Manufacturing Engineering Manager
The Company is also pleased to advise the appointment of Dr Greg Rogers as Manufacturing Engineering Manager, effective from 2 Novemebr 2015.
To read the full announcement please click here.